Risk factor
Strong trading liquidity
Profitability factor
Favourable analyst view
About
PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform for the development of peptides. It has a collaborative research and exclusive license agreement with Takeda Pharmaceutical Company Limited...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITDA, overpr
Target Price
The average target price of 4587.T is 3420 and suggests 126% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
Buy
Sell